India to United Kingdom: Losartan Export Trade Route

The India to United Kingdom Losartan corridor is one of India's established pharmaceutical export routes, with 369 shipments documented worth a combined $8.0M USD. The route is dominated by UNISON PHARMACEUTICALS PRIVATE LIMITED, which alone accounts for roughly 31% of all export value, reflecting the consolidated nature of India's losartan manufacturing sector.

Across 18 active suppliers, the average shipment value stands at $21.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during April–June, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 14.3%, placing it at rank #20 among India's top losartan export destinations globally.

On the import side, key buyers of Indian losartan in United Kingdom include TORRENT PHARMA C/O ALLOGA, MILPHARM LIMITED, BROWN AND BURK UK LIMITED and 34 others. TORRENT PHARMA C/O ALLOGA is the single largest importer with 72 shipments valued at $1.8M USD.

India's losartan exports to United Kingdom are driven primarily by a handful of large-scale manufacturers. UNISON PHARMACEUTICALS PRIVATE LIMITED with 92 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 18 active exporters signals a competitive but concentrated market — buyers in United Kingdom benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — UNISON PHARMACEUTICALS PRIVATE LIMITED, CADILA PHARMACEUTICALS LIMITED, JUBILANT GENERICS LIMITED — together account for 56% of total trade value on this route. The average shipment value of $21.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as losartan potassium 100mg tablets and losartan potassium 100mg tablet r m losartan potassium ph eur batch et911e3001 et911e3009 mfg feb 2023 exp jan 2025, suggesting that buyers in United Kingdom tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TORRENT PHARMA C/O ALLOGA is the largest importer with 72 shipments worth $1.8M USD — representing 22% of all losartan imports from India on this route. A total of 37 buyers are active on this corridor.